Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I study of oral BGJ398 in Asian patients with advanced solid tumors with FGF-R pathway alterations
jRCT2080222231Phase 1Completed
- Start
- Sep 2013
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of infigratinib in Nonhematologic neoplasms. Started Sep 2013; status: completed.
02
Drugs
infigratinib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080222231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222231.